20 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... , a half B-profile ... #BLUE #protocol ... #Algorithm #Dyspnea ... #Pulmonary #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... to the ICU The BLUE-protocol ... , a half B-profile ... #protocol #Algorithm ... #Pulmonary #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... the ICU The BLUE-protocol ... B profile is a half ... , a half B-profile ... dyspnea-criticalcare-pulmonary-algorithm-pocus
Nail Disorders secondary to Systemic Diseases
Nail Fold Abnormality
 • SLE
 • Scleroderma
 • Dermatomyositis
Koilonychia - Spoon-shaped
malnutrition) Blue ... Diabetes Mellitus Half-and-Half ... Systemic #Secondary #dermatology ... #Differential #Diagnosis ... #Algorithm #causes
Petechiae/Purpura - Diagnostic Algorithm. Pathophysiology: 1) Represent the passage of erythrocytes from the intravascular to extravascular
Petechiae/Purpura - Diagnostic ... Algorithm. ... Pathophysiology: ... commonly renal and pulmonary ... Dermatology #Rash
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... Abscess Pathophysiology ... hemorrhage • Treatment ... several months of treatment ... #Abscess #pulmonary
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... for alternate diagnoses ... ventilated • CXR, Lung ... #Exacerbation #treatment ... #pulmonary
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
- Differential Diagnosis ... Algorithm Hodgkin ... Responsive to Treatment ... Classification #pathophysiology ... #Hematology #Diagnosis
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... #diagnosis #comparison
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Tuberculosis Diagnosis ... Tuberculosis Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment